BG-PLATFORM
Live / Applied — Non-final action mailed (as of 26 Aug 2026)
What this means for you
Not registered yet, but its 06 Mar 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79447075
- Mark type
- Stylized text
- Filed
- 06 Mar 2026
Goods and services
- Class 042 — Scientific and technological services: Development of cell therapy products; drug discovery services; development of pharmaceutical preparations and medicines; inspection of pharmaceuticals; analysis and evaluation of medical product development; biomedical research services; research of induced pluripotent stem cells; development of gene-based medicines; culturing of cells for scientific research purposes; research and development of technology for biotechnology.
Owner
- Brexogen Inc., KR
Prosecution history
- 10 Sept 2026 — REFUSAL PROCESSED BY IB
- 26 Aug 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 26 Aug 2026 — REFUSAL PROCESSED BY MPU
- 18 Jun 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 17 Jun 2026 — NON-FINAL ACTION WRITTEN
- 17 Jun 2026 — ASSIGNED TO EXAMINER
- 03 Apr 2026 — APPLICATION FILING RECEIPT MAILED
- 03 Apr 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 02 Apr 2026 — SN ASSIGNED FOR SECT 66A APPL FROM IB